Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Stephen HanauerChinyu Su

Abstract

Tofacitinib is an oral, small molecule inhibitor of JAK for the treatment of ulcerative colitis (UC). We evaluated the onset of symptom improvement in post-hoc analyses of data from 2 phase 3 trials of induction therapy with tofacitinib in patients with UC (OCTAVE Induction 1 and 2). The studies comprised patients with moderate to severe active UC who were intolerant to, or failed by previous treatment with, corticosteroids, thiopurines, and/or tumor necrosis factor (TNF) antagonists. Patients received tofacitinib (10 mg twice daily, n = 905) or placebo (n = 234) for 8 weeks. Daily Mayo stool frequency and rectal bleeding subscores were calculated using diary data from the first 15 days of therapy. We analyzed data from subgroups including failure of prior anti-TNF therapy, baseline corticosteroid use, and baseline serum levels of C-reactive protein. Mean changes were significantly greater in patients given tofacitinib vs placebo in reductions from baseline stool frequency subscore (tofacitinib: -0.27 vs placebo: -0.11; P < .01), total number of daily bowel movements (-1.06 vs -0.27; P < .0001), and rectal bleeding subscore (-0.30 vs -0.14; P < .01) by day 3. Compared with placebo, more tofacitinib-treated patients had reductio...Continue Reading

Citations

Mar 5, 2019·Digestive Diseases and Sciences·Cong DaiMing-Jun Sun
Oct 28, 2019·Expert Review of Gastroenterology & Hepatology·Rocío SedanoAndres J Yarur
Sep 6, 2019·Current Gastroenterology Reports·Christopher M JohnsonThemistocles Dassopoulos
Dec 31, 2019·F1000Research·Bhaskar Gurram, Ashish S Patel
Mar 10, 2020·Expert Opinion on Emerging Drugs·Nicola PuglieseSilvio Danese
Apr 14, 2020·European Journal of Gastroenterology & Hepatology·Laura A LucaciuAndrada Seicean
Apr 26, 2019·Current Opinion in Gastroenterology·Sailish HonapPeter M Irving
Jun 25, 2020·Journal of Crohn's & Colitis·Ferdinando D'AmicoSilvio Danese
Feb 6, 2020·Journal of Crohn's & Colitis·Prashant KotwaniSara Lewin
Dec 28, 2019·Journal of Crohn's & Colitis·Marc Ferrante, João Sabino
Nov 30, 2019·Journal of Crohn's & Colitis·Gerhard Rogler
Jan 11, 2020·Journal of Crohn's & Colitis·Britta Siegmund
Sep 3, 2020·Journal of Pharmacy Practice·Brittany N Palasik, Hongmei Wang
Mar 12, 2020·Current Drug Metabolism·Fabio Salvatore Macaluso, Iago Rodríguez-Lago
Sep 25, 2020·Journal of Crohn's & Colitis·María ChaparroJavier P Gisbert
Jan 8, 2020·Journal of Clinical Medicine·Maia Kayal, Shailja Shah
Feb 1, 2020·Current Gastroenterology Reports·Shannon Chang, David Hudesman
Dec 11, 2019·Journal of Clinical Medicine·Christine VerdonPeter L Lakatos
Mar 24, 2020·Nature Reviews. Gastroenterology & Hepatology·Azucena SalasNiels Vande Casteele
Apr 14, 2020·Journal of Crohn's & Colitis·Sailish HonapUNKNOWN LEO [London, Exeter, Oxford] IBD Research Consortium
Apr 28, 2020·Journal of Inflammation·Amandip Kaur, Paraskevi Goggolidou
Jun 18, 2019·Therapeutic Advances in Gastroenterology·Ferdinando D'AmicoSilvio Danese
Oct 1, 2019·Gastroenterology Research and Practice·Marco DapernoPaolo Gionchetti
May 23, 2020·Clinical and Experimental Gastroenterology·Edoardo TronconeGiovanni Monteleone
Mar 4, 2019·Drugs in R&D·Geert R A M D'HaensStefan Schreiber
Apr 3, 2020·Alimentary Pharmacology & Therapeutics·Vince B C BiemansUNKNOWN Dutch Initiative on Crohn and Colitis (ICC)
Jun 20, 2020·United European Gastroenterology Journal·Fernando Magro, Maria Manuela Estevinho
Aug 3, 2019·Journal of Clinical Gastroenterology·Elisabetta AntonelliGabrio Bassotti
Oct 28, 2020·Expert Review of Gastroenterology & Hepatology·Shu-Chen WeiNana Koram
Dec 10, 2020·Inflammatory Bowel Diseases·Elleni J Pippis, Bruce R Yacyshyn
Nov 1, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William J SandbornBruce E Sands
Apr 18, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Rotem Sigall BonehArie Levine
Feb 9, 2021·Journal of Immunology Research·Junjun ZhaoQiuran Xu
Nov 2, 2020·The Journal of Allergy and Clinical Immunology·William DamskyBrett King
Mar 18, 2021·Clinical and Experimental Gastroenterology·Tom HolvoetPieter Hindryckx
Mar 21, 2021·Inflammatory Bowel Diseases·Isabel GarridoGuilherme Macedo
Mar 24, 2021·Internal and Emergency Medicine·Konstantina Rosiou, Christian Philipp Selinger
Jul 28, 2020·Lancet·Stephan Weidinger, Stefan Schreiber
Apr 23, 2021·Journal of Gastroenterology·Hiroshi NakaseKazuhiko Koike
May 4, 2021·Frontiers in Pharmacology·Badr Al-BawardyDeborah D Proctor
May 15, 2021·Inflammatory Bowel Diseases·Carlos TaxoneraCristina Alba
Mar 19, 2021·Current Opinion in Gastroenterology·Bincy Abraham, Kerri Glassner
May 29, 2021·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jeffrey A BerinsteinPeter D R Higgins
Jun 7, 2021·Lancet·Ariela K Holmer, Siddharth Singh
Jul 9, 2021·Alimentary Pharmacology & Therapeutics·Sailish HonapPeter M Irving
Apr 21, 2019·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Nadia Griller, Lawrence Cohen
Jul 21, 2021·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jonathan M Buscaglia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved